WASHINGTON, Aug 4 (Reuters) – Pharmaceutical company Akorn Inc has won U.S. antitrust approval to buy specialty prescription drug company VersaPharm Inc on condition it sell its rights to a generic…

from Reuters: Mergers News http://ift.tt/1kiUFkB
via IFTTT

Publicités